AMRN - Amarin Corporation - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

27.01M

Cash

308.2M

Avg Qtr Burn

N/A

Short % of Float

4.94%

Insider Ownership

1.55%

Institutional Own.

22.48%

Qtr Updated

03/31/24

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Icosapent Etheyl (generic Vascepa) Details Triglycerides, Heart disease, Cardiovascular disease	Approved Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Vascepa (icosapent ethyl) Details Triglycerides, Heart disease, Cardiovascular disease	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Vascepa (icosapent ethyl) Details Infectious disease, COVID-19	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.